|
WO2012034996A1
|
|
Process for production of l-fucose
|
|
EP2462234A1
|
|
Process for the production of ultrapure galacto-oligosaccharides
|
|
EP2610262A1
|
|
6'-sialyllactose salts and process for their synthesis and for the synthesis of other A-sialyloligosaccharides
|
|
EP2382226A2
|
|
Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof
|
|
WO2007135086A1
|
|
Process for the preparation of n-acetyl-d-mannosamine monohydrate
|
|
KR20060123269A
|
|
Process for the preparation of 1-chloro-3,5-di-o-acyl-2-deoxy-l-ribofuranoside derivatives
|
|
EP1716242A2
|
|
Process for the preparation of galactose
|
|
BRPI0413346A
|
|
polysaccharide derivatives with high antithrombotic plasma activity
|
|
US6891036B2
|
|
Process for the preparation of ribofuranose derivatives
|
|
US6900311B2
|
|
O-sulphated bacterial polysaccharides and their use
|
|
EP1268559A1
|
|
Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
|
|
AU5980600A
|
|
Process for the preparation of the polysaccharides k4 and k5 from escherichia coli
|
|
AU3602499A
|
|
Indole derivatives suitable to be used as chromogenic compounds
|
|
EP0975646A1
|
|
Process for the preparation of a lactulose syrup by lactose isomerization
|
|
EP0970130A2
|
|
Glycosaminoglycans having high antithrombotic activity
|
|
EP0958307A1
|
|
O-sulfated bacterial polysaccharides
|
|
EP0897393A1
|
|
Derivatives of k5 polysaccharide having high anticoagulant activity
|
|
CN1162339A
|
|
Polysaccharides having high iduronic acid content
|
|
US5480491A
|
|
Process for the preparation of crystalline lactulose from commercial syrups
|
|
DK263089D0
|
|
lactulose
|
